Riskpilot← Back to searchSign inGet full accessTobib AB
ABActiveOrg 5590894621Lise Meitners Gata 8Medical specialists activities · NACE 8622Est. 20162 employees
Revenue 2024
SEK 2,1M
-48% vs 2023
EBITDA margin
6.6%
+185% vs 2023
Equity ratio
96.6%
Financial strength
Net profit 2024
SEK 297K
+491% vs 2023
| Revenue | SEK 2,1M | -48% |
| EBITDA | SEK 139K | +185% |
| Net profit | SEK 297K | +491% |
| Total assets | SEK 12,5M | -1% |
| Equity | SEK 12,1M | -1% |
| Employees | 2 | — |
Legal name
Tobib AB
Org number
5590894621
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
7 december 2016
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva hälso- och sjukvård samt därmed förenlig verksamhet. Bolaget skall även rekrytera och bedriva uthyrning av läkare och sjuksköterskor. Bolaget ska även bedriva handel med värdepapper och förvärva och förvalta fastigheter.
Address
Lise Meitners Gata 8
Email
tobibab@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 066 | 5 322 | 4 567 | 4 017 | 2 096 |
| Staff expenses | — | — | −4 789 | −3 945 | −1 647 |
| EBITDA | 4 404 | 3 552 | −721 | −163 | 139 |
| Depreciation & amort. | −21 | −125 | −141 | −143 | −136 |
| EBIT | 4 383 | 3 427 | −862 | −306 | 3 |
| Net financials | 30 | 32 | 55 | 230 | 294 |
| Profit before tax | 4 413 | 3 459 | −807 | −76 | 297 |
| Tax | −945 | −716 | — | — | — |
| Net profit | 3 468 | 2 743 | −807 | −76 | 297 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 031 | 14 291 | 13 171 | 12 657 | 12 492 |
| Equity | 10 988 | 13 631 | 12 644 | 12 168 | 12 065 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 1 043 | 661 | 527 | 489 | 428 |
| Total debt | 1 043 | 661 | 527 | 489 | 428 |
EBITDA margin
6.6%
This company
15.8%
Market median
-58% vs market
20202024
Equity ratio
96.6%
This company
38.2%
Market median
+153% vs market
20202024
Return on equity
2.5%
This company
18.4%
Market median
-86% vs market
20202024
Net profit margin
14.2%
This company
8.1%
Market median
+75% vs market
20202024
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GB Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tobib AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Goran Bahmani Komasi | Audit | 0 companies |
| Sofia Ellinor Osseyran | Deputy Board Member | 0 companies |
| Mohannad Atef Osseyran | Board of Directors | 0 companies |